Trials

A Phase II, Multi-center, Open-label Study of AUY922 Administered IV on a Once-weekly Schedule in Patients With Advanced Non-small-cell Lung Cancer Who Have Received at Least Two Lines of Prior Chemotherapy

Cancer type: Lung cancer

Phase: II

Principal Investigator: Brunsvig Paal

Country: NO

Keywords: Norway, Oslo University Hospital, Non-small-cell lung cancer, NSCLC, HSP90, 3rd line treatment, Oslo

Status: Completed

Link to Clinicaltrials.gov: http://www.clinicaltrials.gov/ct2/show/NCT01124864?term=CAUY922A2206&rank=1